FDA Reveals 4 Year Plan

July 2, 2014 by Arezu Sarvestani

The FDA outlines its vision for the 4 years ahead, generally staying the course on existing initiatives to improve regulatory efficiency, encourage innovation and ensure public health.

The FDA today revealed a draft version of its 4-year plan, laying out strategic priorities and goals for keeping patients and consumers safe while addressing industry concerns.

The agency highlighted 5 primary areas of concern: regulatory science, globalization, safety & quality, smart regulation and stewardship. Regulators plan to focus on these areas over the next 4 years in order to help speed innovations to market, provide the public with the best health information and ensure the security of regulated products.



Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *